These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 26122428
1. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques. Rinne P, Hellberg S, Kiugel M, Virta J, Li XG, Käkelä M, Helariutta K, Luoto P, Liljenbäck H, Hakovirta H, Gardberg M, Airaksinen AJ, Knuuti J, Saraste A, Roivainen A. Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428 [Abstract] [Full Text] [Related]
2. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, Caplin ME. J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077 [Abstract] [Full Text] [Related]
3. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques. Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE, Ylä-Herttuala S, Saukko P, Nuutila P, Roivainen A, Knuuti J. JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786 [Abstract] [Full Text] [Related]
4. 18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study. Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Boeckxstaens L, Dekervel J, Vandamme T, Lybaert W, den Broeck BV, Laenen A, Clement PM, Geboes K, Cutsem EV, Stroobants S, Verslype C, Bormans G, Deroose CM. J Nucl Med; 2023 Apr; 64(4):632-638. PubMed ID: 36265911 [Abstract] [Full Text] [Related]
5. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation. Toner YC, Ghotbi AA, Naidu S, Sakurai K, van Leent MMT, Jordan S, Ordikhani F, Amadori L, Sofias AM, Fisher EL, Maier A, Sullivan N, Munitz J, Senders ML, Mason C, Reiner T, Soultanidis G, Tarkin JM, Rudd JHF, Giannarelli C, Ochando J, Pérez-Medina C, Kjaer A, Mulder WJM, Fayad ZA, Calcagno C. Sci Rep; 2022 Apr 13; 12(1):6185. PubMed ID: 35418569 [Abstract] [Full Text] [Related]
6. Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Li X, Bauer W, Kreissl MC, Weirather J, Bauer E, Israel I, Richter D, Riehl G, Buck A, Samnick S. Atherosclerosis; 2013 Sep 13; 230(1):33-9. PubMed ID: 23958249 [Abstract] [Full Text] [Related]
7. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies. Kiviniemi A, Gardberg M, Autio A, Li XG, Heuser VD, Liljenbäck H, Käkelä M, Sipilä H, Kurkipuro J, Ylä-Herttuala S, Knuuti J, Minn H, Roivainen A. Acta Oncol; 2014 Aug 13; 53(8):1125-34. PubMed ID: 24957558 [Abstract] [Full Text] [Related]
8. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET. Niedermoser S, Chin J, Wängler C, Kostikov A, Bernard-Gauthier V, Vogler N, Soucy JP, McEwan AJ, Schirrmacher R, Wängler B. J Nucl Med; 2015 Jul 13; 56(7):1100-5. PubMed ID: 25977461 [Abstract] [Full Text] [Related]
9. Evaluation of [68Ga]Ga-DOTA-TCTP-1 for the Detection of Metalloproteinase 2/9 Expression in Mouse Atherosclerotic Plaques. Kiugel M, Hellberg S, Käkelä M, Liljenbäck H, Saanijoki T, Li XG, Tuomela J, Knuuti J, Saraste A, Roivainen A. Molecules; 2018 Dec 01; 23(12):. PubMed ID: 30513758 [Abstract] [Full Text] [Related]
13. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with 18F-GE-180, a Radiotracer for Translocator Protein (TSPO). Hellberg S, Liljenbäck H, Eskola O, Morisson-Iveson V, Morrison M, Trigg W, Saukko P, Ylä-Herttuala S, Knuuti J, Saraste A, Roivainen A. Contrast Media Mol Imaging; 2018 Dec 01; 2018():9186902. PubMed ID: 29950954 [Abstract] [Full Text] [Related]
15. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Nakamura I, Hasegawa K, Wada Y, Hirase T, Node K, Watanabe Y. Biochem Biophys Res Commun; 2013 Mar 29; 433(1):47-51. PubMed ID: 23485468 [Abstract] [Full Text] [Related]
17. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Laitinen I, Saraste A, Weidl E, Poethko T, Weber AW, Nekolla SG, Leppänen P, Ylä-Herttuala S, Hölzlwimmer G, Walch A, Esposito I, Wester HJ, Knuuti J, Schwaiger M. Circ Cardiovasc Imaging; 2009 Jul 29; 2(4):331-8. PubMed ID: 19808614 [Abstract] [Full Text] [Related]
18. 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients. Malmberg C, Ripa RS, Johnbeck CB, Knigge U, Langer SW, Mortensen J, Oturai P, Loft A, Hag AM, Kjær A. J Nucl Med; 2015 Dec 29; 56(12):1895-900. PubMed ID: 26429961 [Abstract] [Full Text] [Related]
19. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI. Li X, Bauer W, Israel I, Kreissl MC, Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, Frantz S, Samnick S. Arterioscler Thromb Vasc Biol; 2014 Aug 29; 34(8):1661-7. PubMed ID: 24903095 [Abstract] [Full Text] [Related]